Edwards Makes A Bullish Move As Heart-Valve Replacements Top $1 Billion
In This Article:
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Edwards Lifesciences stock popped Wednesday on strong sales of its TAVR procedures, leading to a top- and bottom-line beat.